Celltrion USA has expanded access to ZYMFENTRA ® (infliximab-dyyb), the first and only FDA-approved subcutaneous (SC) infliximab, to a significant share of the...
Rising international tensions have led to a substantial uptick in global defense spending. The United States alone has committed over $840 billion to...
In recent years, wearable medical devices have made significant strides in healthcare, enabling more effective monitoring and treatment for various conditions. This trend...
In an era defined by rapid advancements in AI and real-time data analytics, edge computing has become indispensable. As data generation surges, driven...
